AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 143 filers reported holding AMICUS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $473,000 | +157.1% | 66,000 | +166.6% | 0.01% | +133.3% |
| Q3 2016 | $184,000 | -86.3% | 24,757 | -89.9% | 0.00% | -86.4% |
| Q2 2016 | $1,344,000 | -66.2% | 246,236 | -12.4% | 0.02% | -56.0% |
| Q2 2015 | $3,979,000 | +0.7% | 281,212 | -22.6% | 0.05% | -9.1% |
| Q1 2015 | $3,952,000 | +330.0% | 363,197 | +228.7% | 0.06% | +358.3% |
| Q4 2014 | $919,000 | +743.1% | 110,496 | +239.9% | 0.01% | +1100.0% |
| Q2 2014 | $109,000 | – | 32,508 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |